Literature DB >> 3229695

Treatment of diabetic foot infections: Wagner classification, therapy, and outcome.

J H Calhoun1, J Cantrell, J Cobos, J Lacy, R R Valdez, J Hokanson, J T Mader.   

Abstract

A total of 850 cases of septic diabetic foot infections were reviewed in 355 patients. Age, sex, other chronic diseases, site, etiology, Wagner grade, treatment, and results were analyzed. One third of the patients were in their sixth decade of life. There were 180 women and 175 men. Chronic diseases included hypertension, congestive heart disease, and renal failure. Staphylococcus aureus was the most common bacteria. Treatment was considered to meet protocol standards if Wagner's algorithms and infectious disease principles were followed. Thirty-nine Wagner grade 0 infections were seen: only one was not treated appropriately. Eighty-eight percent treated per protocol healed and the one not treated appropriately failed. In grade 1, 79% of the 154 evaluable patients were treated appropriately with a 86% success rate versus a 53% success rate for those not treated per protocol. Of three quarters of the 64 patients with grade 2 infections treated according to protocol, 73% healed. One of those in grade 2 who was not treated according to protocol healed. In grade 3, 64% of the 251 patients were treated per protocol with a 79% success rate versus a 12% success rate for those who were not treated per protocol. Most of the 189 patients with grade 4 cases were treated according to protocol with 88% success; the 20 not treated per protocol had a 15% success rate. Thirty of the 32 grade 5 patients were treated per protocol and all but one healed. Protocol therapy had a statistically significant effect by chi 2 test in the treatment of all groups.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3229695     DOI: 10.1177/107110078800900301

Source DB:  PubMed          Journal:  Foot Ankle        ISSN: 0198-0211


  14 in total

Review 1.  Treatment of lower extremity infections in diabetics.

Authors:  W S Joseph
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

Review 2.  Choice of wound care in diabetic foot ulcer: A practical approach.

Authors:  Karakkattu Vijayan Kavitha; Shalbha Tiwari; Vedavati Bharat Purandare; Sudam Khedkar; Shilpa Sameer Bhosale; Ambika Gopalakrishnan Unnikrishnan
Journal:  World J Diabetes       Date:  2014-08-15

3.  Angiosome-targeted revascularisation in diabetic foot ulcers.

Authors:  Raffaele Serra; Raffaele Grande; Edoardo Scarcello; Gianluca Buffone; Stefano de Franciscis
Journal:  Int Wound J       Date:  2013-10-07       Impact factor: 3.315

Review 4.  Bone and joint infections in the elderly: practical treatment guidelines.

Authors:  J T Mader; M E Shirtliff; S Bergquist; J H Calhoun
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

5.  Osteomyelitis of the long bones.

Authors:  Jason H Calhoun; M M Manring; Mark Shirtliff
Journal:  Semin Plast Surg       Date:  2009-05       Impact factor: 2.314

6.  Evidence of differential microbiomes in healing versus non-healing diabetic foot ulcers prior to and following foot salvage therapy.

Authors:  Ashlee MacDonald; James D Brodell; John L Daiss; Edward M Schwarz; Irvin Oh
Journal:  J Orthop Res       Date:  2019-03-28       Impact factor: 3.494

Review 7.  Classification of wounds of the diabetic foot.

Authors:  D G Armstrong; E J Peters
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

8.  Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK.

Authors:  Jeroen P Jansen; Ritesh Kumar; Yehuda Carmeli
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

9.  Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial.

Authors:  Benjamin A Lipsky; Peter Sheehan; David G Armstrong; Alan D Tice; Adam B Polis; Murray A Abramson
Journal:  Int Wound J       Date:  2007-03       Impact factor: 3.315

10.  On the decision rules of cost-effective treatment for patients with diabetic foot syndrome.

Authors:  John E Goulionis; Athanassios Vozikis; Vk Benos; D Nikolakis
Journal:  Clinicoecon Outcomes Res       Date:  2010-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.